2019 Q3 Form 10-Q Financial Statement

#000164033419002415 Filed on November 19, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2018 Q3
Revenue $135.00 $78.00
YoY Change 73.08% -91.65%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $60.00K $40.00K
YoY Change 50.0% -75.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $6.500K
YoY Change -100.0% -39.86%
% of Gross Profit
Operating Expenses $55.30K $44.32K
YoY Change 24.78% -74.36%
Operating Profit -$55.16K -$44.24K
YoY Change 24.69% -74.27%
Interest Expense -$20.05K -$42.58K
YoY Change -52.9% -142.38%
% of Operating Profit
Other Income/Expense, Net -$32.30K -$173.3K
YoY Change -81.37% -26.14%
Pretax Income -$90.00K -$220.0K
YoY Change -59.09% -46.34%
Income Tax
% Of Pretax Income
Net Earnings -$87.46K -$217.6K
YoY Change -59.8% -46.49%
Net Earnings / Revenue -64784.44% -278943.59%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$0.04
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.00K $20.00K
YoY Change -50.0%
Cash & Equivalents $11.56K $22.69K
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change
Inventory
Prepaid Expenses $2.000K
Receivables
Other Receivables
Total Short-Term Assets $13.56K $22.69K
YoY Change -40.26% 4040.33%
LONG-TERM ASSETS
Property, Plant & Equipment $800.00
YoY Change -97.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $800.00
YoY Change -100.0% -97.17%
TOTAL ASSETS
Total Short-Term Assets $13.56K $22.69K
Total Long-Term Assets $0.00 $800.00
Total Assets $13.56K $23.49K
YoY Change -42.29% -18.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $40.00K $270.0K
YoY Change -85.19% 170.0%
Accrued Expenses $20.00K $250.0K
YoY Change -92.0% 66.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $330.0K $340.0K
YoY Change -2.94% 142.86%
Total Short-Term Liabilities $1.067M $2.091M
YoY Change -48.94% 224.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.067M $2.091M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.067M $2.091M
YoY Change -48.94% 224.65%
SHAREHOLDERS EQUITY
Retained Earnings -$7.929M -$6.995M
YoY Change 13.36% 34.79%
Common Stock $516.1K $124.0K
YoY Change 316.06% 71.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.054M -$2.067M
YoY Change
Total Liabilities & Shareholders Equity $13.56K $23.49K
YoY Change -42.29% -18.4%

Cashflow Statement

Concept 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income -$87.46K -$217.6K
YoY Change -59.8% -46.49%
Depreciation, Depletion And Amortization $0.00 $6.500K
YoY Change -100.0% -39.86%
Cash From Operating Activities -$33.53K -$24.58K
YoY Change 36.37% -43.96%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $25.00 $77.00
YoY Change -67.53% -95.84%
NET CHANGE
Cash From Operating Activities -$33.53K -$24.58K
Cash From Investing Activities
Cash From Financing Activities $25.00 $77.00
Net Change In Cash -$33.50K -$24.51K
YoY Change 36.7% -41.68%
FREE CASH FLOW
Cash From Operating Activities -$33.53K -$24.58K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q3 dei Entity Registrant Name
EntityRegistrantName
APPYEA, INC
CY2019Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001568969
CY2019Q3 dei Document Type
DocumentType
10-Q
CY2019Q3 dei Amendment Flag
AmendmentFlag
false
CY2019Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2019Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2019Q3 dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019Q3 dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
CY2019Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5161140774 shares
CY2019Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
11555 usd
CY2019Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
45056 usd
CY2019Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2000 usd
CY2019Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9500 usd
CY2019Q3 us-gaap Assets Current
AssetsCurrent
13555 usd
CY2019Q2 us-gaap Assets Current
AssetsCurrent
54556 usd
CY2019Q3 us-gaap Assets
Assets
13555 usd
CY2019Q2 us-gaap Assets
Assets
54556 usd
CY2019Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
40531 usd
CY2019Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
44393 usd
CY2019Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
21506 usd
CY2019Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
3506 usd
CY2019Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
332676 usd
CY2019Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
315232 usd
CY2019Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
88249 usd
CY2019Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
88224 usd
CY2019Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
584534 usd
CY2019Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
578812 usd
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1067496 usd
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1030167 usd
CY2019Q3 us-gaap Liabilities
Liabilities
1067496 usd
CY2019Q2 us-gaap Liabilities
Liabilities
1030167 usd
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
975 usd
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
975 usd
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
516114 usd
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
509593 usd
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6310631 usd
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6308023 usd
CY2019Q3 apyp Stock Payable
StockPayable
47727 usd
CY2019Q2 apyp Stock Payable
StockPayable
47727 usd
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7929388 usd
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7841929 usd
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-1053941 usd
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-975611 usd
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13555 usd
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54556 usd
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
60000000 shares
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
60000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
9750000 shares
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
9750000 shares
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
9750000 shares
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
9750000 shares
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5095935524 shares
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5161140774 shares
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5095935524 shares
CY2019Q3 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
8699 usd
CY2019Q2 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
15000 usd
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5161140774 shares
CY2019Q3 us-gaap Revenues
Revenues
135 usd
CY2018Q3 us-gaap Revenues
Revenues
78 usd
CY2019Q3 us-gaap Professional Fees
ProfessionalFees
28879 usd
CY2018Q3 us-gaap Professional Fees
ProfessionalFees
9561 usd
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26420 usd
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28257 usd
CY2019Q3 us-gaap Depreciation
Depreciation
usd
CY2018Q3 us-gaap Depreciation
Depreciation
6500 usd
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
55299 usd
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
44318 usd
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-55164 usd
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-44240 usd
CY2019Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-12243 usd
CY2018Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-130761 usd
CY2019Q3 us-gaap Interest Expense
InterestExpense
-20052 usd
CY2018Q3 us-gaap Interest Expense
InterestExpense
-42575 usd
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32295 usd
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-173336 usd
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-87459 usd
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-217576 usd
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5095935524 shares
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1240477060 shares
CY2018Q2 us-gaap Shares Issued
SharesIssued
shares
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-1849568 usd
CY2018Q3 us-gaap Shares Issued
SharesIssued
shares
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-2067144 usd
CY2019Q2 us-gaap Shares Issued
SharesIssued
shares
CY2019Q3 us-gaap Shares Issued
SharesIssued
shares
CY2019Q3 apyp Common Stock Issued For Conversion Of Debt And Resolution Of Derivative Liabilities Amount
CommonStockIssuedForConversionOfDebtAndResolutionOfDerivativeLiabilitiesAmount
9129 usd
CY2019Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6301 usd
CY2018Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
24974 usd
CY2019Q3 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
12243 usd
CY2018Q3 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
130761 usd
CY2019Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7500 usd
CY2018Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2019Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3862 usd
CY2018Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8369 usd
CY2019Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
18000 usd
CY2018Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
21525 usd
CY2019Q3 us-gaap Line Of Credit Facility Increase Accrued Interest
LineOfCreditFacilityIncreaseAccruedInterest
13751 usd
CY2018Q3 us-gaap Line Of Credit Facility Increase Accrued Interest
LineOfCreditFacilityIncreaseAccruedInterest
17601 usd
CY2019Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33526 usd
CY2018Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24584 usd
CY2019Q3 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
25 usd
CY2018Q3 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
377 usd
CY2019Q3 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
usd
CY2018Q3 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
-300 usd
CY2019Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25 usd
CY2018Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
77 usd
CY2019Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-33501 usd
CY2018Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-24507 usd
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45056 usd
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47196 usd
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22689 usd
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11555 usd
CY2019Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2018Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2019Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2018Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2019Q3 apyp Issuance Of Common Stock For Conversion Of Debt And Accrued Interest
IssuanceOfCommonStockForConversionOfDebtAndAccruedInterest
2608 usd
CY2018Q3 apyp Issuance Of Common Stock For Conversion Of Debt And Accrued Interest
IssuanceOfCommonStockForConversionOfDebtAndAccruedInterest
usd
CY2019Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
6521 usd
CY2018Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
usd
CY2019Q3 us-gaap Nature Of Operations
NatureOfOperations
<div style="font: 10pt TIMES NEW ROMAN; text-align: justify;"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">AppYea, Inc. (&#8220;AppYea&#8221;, &#8220;the Company&#8221;, &#8220;we&#8221; or &#8220;us&#8221;) was incorporated in the State of South Dakota on November 26, 2012 to engage in the acquisition, purchase, maintenance and creation of mobile software applications. The Company is in the development stage with no significant revenues and a limited operating history.</p><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">The Company incorporated a wholly-owned subsidiary, &#8220;AppYea Holdings, Inc.&#8221; in state of South Dakota on January 13, 2017 and &#8220;The Diagnostic Centers Inc.&#8221; in State of South Dakota on August 2, 2017.</p><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">Through its wholly owned subsidiary, The Diagnostic Centers, Inc., AppYea markets comprehensive diagnostic testing services to physician offices, clinics, hospitals, long term care facilities, healthcare groups, and other healthcare providers.</p><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">During the quarter ended March 31, 2019 the Company entered into a management and advisory agreement with Hempori, Inc. to assist the Company in identifying and managing the Company&#8217;s overall business strategy and opportunities to enter the hemp based Cannabidiol (CBD) industry. Additionally, the Company entered into an exclusive CBD infused beverage licensing agreement with the Prouty Company to market flavored and non-flavored beverages in various formulas infused with CBD to achieve the following &#8220;mood enhancing&#8221; affects: Energy, Calm, Focus, and Sleep.</p><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p><p style="margin:0px;Font:10pt Times New Roman;padding:0px">The Company&#8217;s common stock is traded on the OTC Markets (www.otcmarkets.com) under the symbol &#8220;APYP&#8221;.</p></div>
CY2019Q3 us-gaap Use Of Estimates
UseOfEstimates
<div style="font: 10pt TIMES NEW ROMAN; text-align: justify;"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions about the valuation and recognition of stock-based compensation expense, the valuation and recognition of derivative liability, valuation allowance for deferred tax assets and useful life of fixed assets.</p></div>
CY2019Q3 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font: 10pt TIMES NEW ROMAN; text-align: justify;"><p style="margin:0px;Font:10pt Times New Roman;padding:0px">Certain amounts from prior periods have been reclassified to conform to the current period presentation.</p></div>
CY2019Q3 apyp Fair Value Assets Measured On Recurring Basis
FairValueAssetsMeasuredOnRecurringBasis
<div style="font: 10pt TIMES NEW ROMAN; text-align: justify;"><p style="margin:0px;Font:10pt Times New Roman;padding:0px">&nbsp;</p><table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"><tr><td style="BORDER-BOTTOM: 1px solid" valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"><b>September 30, 2019</b></p></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="center"><b>Level 1</b></p></td><td valign="bottom"></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="center"><b>Level 2</b></p></td><td valign="bottom"></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="center"><b>Level 3</b></p></td><td valign="bottom"></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="center"><b>Total</b></p></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td></tr><tr><td valign="top"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"><b>Assets</b></p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%" colspan="2"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%" colspan="2"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%" colspan="2"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%" colspan="2"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">None</p></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td></tr><tr bgcolor="#ffffff"><td></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"><b>Liabilities</b></p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">Derivative liabilities</p></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">584,534</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">584,534</p></td><td valign="bottom" width="1%"></td></tr></table><p style="margin:0px;Font:10pt Times New Roman;padding:0px">&nbsp;</p><table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0"><tr><td style="BORDER-BOTTOM: 1px solid" valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"><b>June 30, 2019</b></p></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="center"><b>Level 1</b></p></td><td valign="bottom"></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="center"><b>Level 2</b></p></td><td valign="bottom"></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="center"><b>Level 3</b></p></td><td valign="bottom"></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="center"><b>Total</b></p></td><td valign="bottom"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td></tr><tr><td valign="top"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"><b>Assets</b></p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%" colspan="2"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%" colspan="2"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%" colspan="2"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%" colspan="2"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">None</p></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td></tr><tr bgcolor="#ffffff"><td></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify"><b>Liabilities</b></p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" width="9%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">Derivative liabilities</p></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">-</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">578,812</p></td><td valign="bottom" width="1%"></td><td valign="bottom" width="1%"><p style="margin:0px;Font:10pt Times New Roman;padding:0px" align="justify">&nbsp;</p></td><td valign="bottom" width="1%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="justify">$</p></td><td valign="bottom" width="9%"><p style="margin:0px 0px 0px 0in;Font:10pt Times New Roman;padding:0px" align="right">578,812</p></td><td valign="bottom" width="1%"></td></tr></table><p style="margin:0px;Font:10pt Times New Roman;padding:0px">&nbsp;</p></div>
CY2019Q3 apyp State Of Incorporation
StateOfIncorporation
Dakota
CY2019Q3 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2012-11-26
CY2019Q3 apyp Working Capital Surplus Deficit
WorkingCapitalSurplusDeficit
-1053941 usd
CY2019Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
301438 usd
CY2019Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
299330 usd
CY2019Q2 us-gaap Interest Payable Current
InterestPayableCurrent
28794 usd
CY2019Q3 us-gaap Interest Payable Current
InterestPayableCurrent
42045 usd
CY2019Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
-15000 usd
CY2019Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
-8699 usd
CY2019Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
315232 usd
CY2019Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
332676 usd
CY2019Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
315232 usd
CY2019Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
332676 usd
CY2019Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2019Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2019Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1586098636 shares
CY2019Q3 apyp Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
0 shares
CY2019Q3 apyp Class Of Warrant Or Right With Reset Feature
ClassOfWarrantOrRightWithResetFeature
0 shares
CY2019Q3 apyp Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
CY2019Q3 apyp Class Of Warrant Or Right Forfeited Or Cancellation
ClassOfWarrantOrRightForfeitedOrCancellation
0 shares
CY2019Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1586098636 shares
CY2019Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0002
CY2019Q3 apyp Class Of Warrant Or Right Weighted Average Exercise Price Granted
ClassOfWarrantOrRightWeightedAverageExercisePriceGranted
0
CY2019Q3 apyp Class Of Warrant Or Right Weighted Average Exercise Price With Reset Feature
ClassOfWarrantOrRightWeightedAverageExercisePriceWithResetFeature
0
CY2019Q3 apyp Class Of Warrant Or Right Weighted Average Exercise Price Exercised
ClassOfWarrantOrRightWeightedAverageExercisePriceExercised
0
CY2019Q3 apyp Class Of Warrant Or Right Weighted Average Exercise Price Forfeited Or Canceled
ClassOfWarrantOrRightWeightedAverageExercisePriceForfeitedOrCanceled
0
CY2019Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0002
CY2019Q3 apyp Warrants Outstanding Weighted Average Remaining Contractual Life
WarrantsOutstandingWeightedAverageRemainingContractualLife
P2Y0M18D
CY2019Q3 apyp Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1586098636 shares
CY2019Q3 apyp Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
0.0002
CY2018Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
usd
CY2019Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
usd
CY2018Q3 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
-6521 usd
CY2019Q3 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
2608 usd
CY2018Q3 apyp Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
usd
CY2019Q3 apyp Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
85000 usd
CY2018Q3 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
usd
CY2019Q3 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
302038 usd
CY2018Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
shares
CY2019Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
65205250 shares
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
usd
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
-6521 usd
CY2019Q3 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
387038 usd
CY2018Q2 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
usd
CY2018Q3 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2019Q3 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
142167 usd
CY2019Q3 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
38447 usd
CY2019Q3 us-gaap Debt Default Longterm Debt Amount
DebtDefaultLongtermDebtAmount
116666 usd
CY2019Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
578812 usd
CY2019Q3 apyp Settled Due To Conversion Of Debt
SettledDueToConversionOfDebt
-6521 usd
CY2019Q3 apyp Loss On Change In Fair Value Of The Derivative
LossOnChangeInFairValueOfTheDerivative
12243 usd
CY2019Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
584534 usd
CY2013Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200 usd
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
50000 usd
CY2018Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
623 usd
CY2019Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
623 usd
CY2013Q1 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P3M
CY2013Q1 us-gaap Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
Three-month periods unless there is the notice to cancel. The lease can be cancelled at any time by either party with 30 days' notice prior to expiration of an applicable term.

Files In Submission

Name View Source Status
0001640334-19-002415-index-headers.html Edgar Link pending
0001640334-19-002415-index.html Edgar Link pending
0001640334-19-002415.txt Edgar Link pending
0001640334-19-002415-xbrl.zip Edgar Link pending
apyp-20190930.xsd Edgar Link pending
apyp_10q.htm Edgar Link pending
apyp_ex311.htm Edgar Link pending
apyp_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
apyp-20190930_def.xml Edgar Link unprocessable
apyp-20190930.xml Edgar Link completed
apyp-20190930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
apyp-20190930_pre.xml Edgar Link unprocessable
apyp-20190930_cal.xml Edgar Link unprocessable